Skip to main content
Equibles

MORGAN STANLEY

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$114,996,535
-$21,394,143 QoQ
Shares Held
1,827,082
-6.0% QoQ
Ownership
4.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 256 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TARS ranks #33 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in TARS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $114,996,535 1,827,082
2026-03-31 $136,390,678 1,944,272
2025-12-31 $167,095,951 2,040,742
2025-09-30 $113,654,045 1,912,402
2025-06-30 $83,277,132 2,055,718
2025-03-31 $103,396,349 2,012,777
2024-12-31 $109,027,456 1,969,071
2024-09-30 $72,640,455 2,208,588
2024-06-30 $51,225,734 1,884,685
2024-03-31 $87,200,666 2,398,918
2023-12-31 $39,643,179 1,957,688
2023-09-30 $1,311,760 73,819
2023-06-30 $904,959 50,081
2023-03-31 $404,687 32,195
2022-12-31 $364,400 24,857
2022-09-30 $415,499 24,270
2022-06-30 $512,736 35,119
2022-03-31 $188,568 11,211
2021-12-31 $252,854 11,238
2021-09-30 $614,820 28,530
2021-06-30 $240,011 8,282
2020-12-31 $263,354 6,372